In episode 6 get to know the computational biologist Aviv Regev and the medical researcher Judith Feucht. Both women are pioneers in their field: Aviv Regev has advanced the fundamentals of single-cell genomics, and Judith Feucht develops anti-cancer immunotherapies by modifying endogenous T-cells. The two prize winners share a strong intrinsic motivation to translate their basic research into clinical application: How can clinical routine and research be combined, and what drives a successful scientist to resign from one of the most prestigious academic chairs to work for the pharmaceutical industry? You will also find out what impact Aviv Regev’s research field – the development of single-cell genomics – has on the work of Judith Feucht. To what extent is the Human Cell Atlas not only an important tool in medicine but also a perfect example of a collaborative science project? What do the prize winners think of gender equality in science, and what is their greatest mission? The science journalist Julia Vismann moderates the conversation between the 2021 Ernst Schering Prize recipient Prof. Aviv Regev, PhD, Global Head of Genentech Research and Early Development, and Dr. Judith Feucht, medical doctor and research group leader at Tübingen University Hospital, who was awarded the 2021 Friedmund Neumann Prize. The podcast is in English.